Cargando…
β-TrCP1 degradation is a novel action mechanism of PI3K/mTOR inhibitors in triple-negative breast cancer cells
An F-box protein, β-TrCP recognizes substrate proteins and destabilizes them through ubiquitin-dependent proteolysis. It regulates the stability of diverse proteins and functions as either a tumor suppressor or an oncogene. Although the regulation by β-TrCP has been widely studied, the regulation of...
Autores principales: | Yi, Yong Weon, Kang, Hyo Jin, Bae, Edward Jeong, Oh, Seunghoon, Seong, Yeon-Sun, Bae, Insoo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4346488/ https://www.ncbi.nlm.nih.gov/pubmed/25721419 http://dx.doi.org/10.1038/emm.2014.127 |
Ejemplares similares
-
SCF(βTrCP)-mediated degradation of SHARP1 in triple-negative breast cancer
por: Enriqué Steinberg, Juliana Haydeé, et al.
Publicado: (2023) -
Small molecule and peptide inhibitors of βTrCP and the βTrCP–NRF2 protein–protein interaction
por: Jaffry, Uzma, et al.
Publicado: (2023) -
Degradation of helicase-like transcription factor (HLTF) by β-TrCP promotes hepatocarcinogenesis via activation of the p62/mTOR axis
por: Tan, Ye, et al.
Publicado: (2023) -
Plk1- and β-TrCP–dependent degradation of Bora controls mitotic progression
por: Seki, Akiko, et al.
Publicado: (2008) -
β-TrCP-mediated ubiquitination and degradation of liver-enriched transcription factor CREB-H
por: Cheng, Yun, et al.
Publicado: (2016)